Search
iNYX Technology Achieves Series D Funding Success as a Premier Medical Chip Company
11 hour ago /
Read about 0 minute
Author：小编
Recently, iNYX Technology, a frontrunner in China's ophthalmic neuromodulation and high-end medical chip sectors, has triumphantly concluded its Series D equity financing round. This significant funding initiative was spearheaded by the Aibo Hongsheng Fund, with notable contributions from entities including the Beijing Medical and Health Industry Investment Fund and Guokai Venture Capital. The influx of capital will be strategically allocated towards advancing research and development in visual brain-computer interface technology, expediting the clinical application of key products, and bolstering efforts in global market penetration and industrialization infrastructure development.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
